about
Exogenous HIV-1 Nef upsets the IFN-γ-induced impairment of human intestinal epithelial integrityReal-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort StudyGlances in Immunology of HIV and HCV InfectionEffects of HIV-1 Nef on virus co-receptor expression and cytokine release in human bladder, laryngeal, and intestinal epithelial cell lines.Cytotoxic necrotizing factor 1 enhances reactive oxygen species-dependent transcription and secretion of proinflammatory cytokines in human uroepithelial cells.Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort.The Rac-activating toxin cytotoxic necrotizing factor 1 oversees NK cell-mediated activity by regulating the actin/microtubule interplay.Dilitiazem reduces nitric oxide production by human immune cells.Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease.Redox imbalance and immune functions: opposite effects of oxidized low-density lipoproteins and N-acetylcysteine.HIV-1 Nef induces dendritic cell differentiation: a possible mechanism of uninfected CD4(+) T cell activation.N-acetylcysteine inhibits the induction of an antigen-specific antibody response down-regulating CD40 and CD27 co-stimulatory molecules.HIV-1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells.Effect of indinavir used alone or in double or triple combination with AZT and ddC on human immune functions.Lack of immunotoxicity of saquinavir (Ro 31-8959) used alone or in double or triple combination with AZT and ddC.IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.Leptin exerts an anti-apoptotic effect on human dendritic cells via the PI3K-Akt signaling pathway.Impaired NK-cell-mediated cytotoxic activity and cytokine production in patients with endometriosis: a possible role for PCBs and DDE.HIV-1 Nef equips dendritic cells to reduce survival and function of CD8+ T cells: a mechanism of immune evasion.HIV-1 Nef impairs the dynamic of DC/NK crosstalk: different outcome of CD56(dim) and CD56(bright) NK cell subsets.Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?Leptin as an immunological adjuvant: enhanced migratory and CD8+ T cell stimulatory capacity of human dendritic cells exposed to leptinDifferentiation of monocyte-derived dendritic cells is associated with upregulation and activation of Rac-1 small GTPaseInduction of Interleukin-15 Production by HIV-1 Nef Protein: A Role in the Proliferation of Uninfected CellsMildly oxidized low-density lipoprotein inhibits the in vitro induction of the specific antibody response to Candida albicansLeptin Promotes Differentiation and Survival of Human Dendritic Cells and Licenses Them for Th1 PrimingHIV-1 Nef protein inhibits the in vitro induction of a specific antibody response to Candida albicans by an early up-regulation of IL-15 productionDiltiazem modulates monokine production by isolated human monocytes
P50
Q28741652-B476F18C-B240-4136-A662-C6F0897FC049Q31168033-5D7403E2-E286-4491-821E-08ECD7229AC9Q36032051-CBEE51DB-78D4-4F46-BAB8-4908A6568E0DQ39525607-F4669D33-93BF-45E4-BF75-264733720C75Q39777000-8585C43C-3864-48AE-B17F-EA0E9DA3CFB2Q40121053-3AE5A2F3-E5F5-490A-B8FB-50E5C416AC1BQ40557652-B59252C0-4254-46A7-8837-A72249FC2B45Q40802912-176FDD7E-9F95-4470-9907-BA2980DAAF64Q43456878-33B90AA1-BBA2-45B7-B012-886B27BD31C3Q43920734-6E3F94FB-CE11-49D3-BE29-C26581EAFDEBQ43968540-11E95931-93D9-4A85-9388-B497F82867F9Q44091860-32C2DFE7-9C36-446B-801D-F1F61BD01653Q44642079-FB5B8EB2-364A-4029-AB2B-992D5E17F45BQ44779012-B1C8F1D1-2331-4786-A1B9-817A27548BDFQ44901448-914966EA-A41C-4DBD-98B2-723F7E1AC554Q46032985-0481D98D-1297-4665-BAFE-265F699FE083Q46105132-7ED31D94-F54B-407D-8431-E6577D3EC3C0Q46962208-1F9A55C5-AA69-457B-95D1-0CF917910953Q47232700-9B01A91E-CF2A-4F7C-8A55-AF46C3FF1F4DQ53559837-33F991E0-F764-4D00-9FE2-8349A21ADEAEQ56379401-B2157A2E-A718-411C-BC63-B8E2D523A868Q60687722-82E4443D-9FD8-4A58-A500-0B5DFC4A3665Q60687729-8A6A8DC9-ED77-46BA-B50A-8DA5C06BC573Q60687751-C7860692-F103-4113-AA13-CAE4F797AB11Q62566170-7CDC7C80-CAD1-4DD9-B1D7-892DE83A48A2Q62566171-2C8018C0-0A54-4DA7-A8C0-C78A5FFFBA8EQ62566178-714A0CA9-C5D4-4923-A442-45EC35A48244Q62566182-57533EA9-6F69-4426-9BF7-53B59010D29F
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria Giovanna Quaranta
@ast
Maria Giovanna Quaranta
@en
Maria Giovanna Quaranta
@es
Maria Giovanna Quaranta
@nl
Maria Giovanna Quaranta
@sl
type
label
Maria Giovanna Quaranta
@ast
Maria Giovanna Quaranta
@en
Maria Giovanna Quaranta
@es
Maria Giovanna Quaranta
@nl
Maria Giovanna Quaranta
@sl
prefLabel
Maria Giovanna Quaranta
@ast
Maria Giovanna Quaranta
@en
Maria Giovanna Quaranta
@es
Maria Giovanna Quaranta
@nl
Maria Giovanna Quaranta
@sl
P106
P21
P31
P496
0000-0002-1077-1488